EP2477985
CRLX101 FOR USE IN THE TREATMENT OF CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
15.9.2010EP published:
7.11.2018EP application number:
10817784.1
EPO information:
European Patent Register
Max expiry date:
14.9.2030
Title:
CRLX101 FOR USE IN THE TREATMENT OF CANCER
Timeline
Today
15.9.2010EP application
7.11.2018EP Publication
Owner
Name:
BlueLink Pharmaceuticals, Inc.Address:
2503 S. Loop Drive, Ste 5100, 50010, Ames, Iowa, US
Inventor
Name:
YEN, YunAddress:
Arcadia, CA, US
Name:
SCHLUEP, ThomasAddress:
Las Cresenta, CA, US
Name:
RYAN, JohnAddress:
Philadelphia, PA, US
Name:
DAVIS, MarkAddress:
Pasadena, CA, US
Name:
OLIVER, James, C.Address:
Raleigh, NC, US
Priority
Number:
242752 PDate:
15.9.2009Country:
US
Number:
317039 PDate:
24.3.2010Country:
US
Number:
332150 PDate:
6.5.2010Country:
US
Number:
381851 PDate:
10.9.2010Country:
US
Classification
Categories:
A61K 31/724, A61P 35/00, A61K 47/61